Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Trimethylamine N-oxide (TMAO)-Reducing Effects of a Pomegranate Supplement Simultaneously Administered With L-carnitine

NCT06518343 is registered in ClinicalTrials.gov with Quadram Institute Bioscience as lead sponsor.

NCT NCT06518343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06518343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Trimethylamine N-oxide (TMAO)-Reducing Effects of a Pomegranate Supplement Simultaneously Administered With L-carnitine
Lead sponsor
Quadram Institute Bioscience
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 12, 2024
Completion date
May 31, 2027
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy